Surgical Innovations Group plc

AIM:SUN Stok Raporu

Piyasa değeri: UK£5.1m

Surgical Innovations Group Yönetim

Yönetim kriter kontrolleri 3/4

Surgical Innovations Group CEO'su David Marsh, Feb2019 tarihinde atandı, in görev süresi 5.75 yıldır. in toplam yıllık tazminatı £ 219.00K olup, şirket hissesi ve opsiyonları dahil olmak üzere 94.1% maaş ve 5.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 3.38% ine doğrudan sahiptir ve bu hisseler £ 173.59K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 11.4 yıldır.

Anahtar bilgiler

David Marsh

İcra Kurulu Başkanı

UK£219.0k

Toplam tazminat

CEO maaş yüzdesi94.1%
CEO görev süresi5.8yrs
CEO sahipliği3.4%
Yönetim ortalama görev süresi3.8yrs
Yönetim Kurulu ortalama görev süresi11.4yrs

Son yönetim güncellemeleri

Recent updates

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Jul 11
Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19
Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29
Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07
Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26
Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Jun 15
Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Sep 24
Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Mar 29
Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

CEO Tazminat Analizi

David Marsh'un ücretlendirmesi Surgical Innovations Group'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-UK£622k

Mar 31 2024n/an/a

-UK£565k

Dec 31 2023UK£219kUK£206k

-UK£509k

Sep 30 2023n/an/a

-UK£302k

Jun 30 2023n/an/a

-UK£96k

Mar 31 2023n/an/a

UK£84k

Dec 31 2022UK£211kUK£198k

UK£264k

Sep 30 2022n/an/a

-UK£56k

Jun 30 2022n/an/a

-UK£376k

Mar 31 2022n/an/a

-UK£416k

Dec 31 2021UK£201kUK£187k

-UK£456k

Sep 30 2021n/an/a

-UK£635k

Jun 30 2021n/an/a

-UK£815k

Mar 31 2021n/an/a

-UK£2m

Dec 31 2020UK£175kUK£162k

-UK£3m

Sep 30 2020n/an/a

-UK£4m

Jun 30 2020n/an/a

-UK£5m

Mar 31 2020n/an/a

-UK£4m

Dec 31 2019UK£186kUK£173k

-UK£3m

Sep 30 2019n/an/a

-UK£1m

Jun 30 2019n/an/a

UK£300k

Mar 31 2019n/an/a

UK£513k

Dec 31 2018UK£161kUK£122k

UK£725k

Sep 30 2018n/an/a

UK£521k

Jun 30 2018n/an/a

UK£317k

Mar 31 2018n/an/a

UK£403k

Dec 31 2017UK£126kUK£51k

UK£488k

Tazminat ve Piyasa: David 'ın toplam tazminatı ($USD 274.08K ) UK pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 356.31K ).

Tazminat ve Kazançlar: David şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

David Marsh (60 yo)

5.8yrs

Görev süresi

UK£219,000

Tazminat

Mr. David John Marsh has been the Chief Executive Officer of Surgical Innovations Group plc since February 28, 2019. Mr. Marsh served as the Group Commercial Director at Surgical Innovations Group plc on t...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
David Marsh
CEO & Director5.8yrsUK£219.00k3.38%
£ 173.6k
Christopher Martin
CFO & Executive Directorless than a yearVeri yokVeri yok
Alex Hogg
Operations Director5.7yrsVeri yokVeri yok
Stephen Seed
Chief Compliance Officerno dataVeri yokVeri yok
Julia Taylor
HR Director1.3yrsVeri yokVeri yok
Damian Donnelly
Chief Commercial Officer3.8yrsVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: SUN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
David Marsh
CEO & Director7.3yrsUK£219.00k3.38%
£ 173.6k
Christopher Martin
CFO & Executive Directorless than a yearVeri yokVeri yok
Jonathan Glenn
Senior Independent Non-Executive Director & Chairman1.5yrsUK£24.00k0.14%
£ 7.2k
Michael McMahon
Member of Clinical Advisory Boardno dataUK£19.00kVeri yok
Ian Brayshaw
Member of the Clinical Advisory Boardno dataVeri yokVeri yok
Philippe Grange
Member of the Clinical Advisory Boardno dataVeri yokVeri yok
Keyvan Djamarani
Independent Non-executive Directorless than a yearUK£2.00kVeri yok
Marco Adamo
Member of the Clinical Advisory Board13.8yrsVeri yokVeri yok
James Halstead
Member of the Clinical Advisory Board12.8yrsVeri yokVeri yok
Chris Sutton
Member of the Clinical Advisory Board12.8yrsVeri yokVeri yok
John Griffith
Member of the Clinical Advisory Board11.9yrsVeri yokVeri yok
Henrik Steinbrecher
Member of the Clinical Advisory Board11.4yrsVeri yokVeri yok

11.4yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SUN 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11.4 yıldır).